Prasad Wealth Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$351K Buy
1,553
+103
+7% +$21.8K 0.08% 117
2026
Q2
$313K Hold
1,450
– – 0.08% 118
2026
Q1
$266K Sell
1,450
-2
-0.1% -$369 0.07% 117
2025
Q4
$256K Hold
1,452
– – 0.07% 121
2025
Q3
$203K Buy
+1,452
New +$196K 0.06% 135
2025
Q1
– Sell
-1,450
Closed -$222K – 117
2024
Q4
$222K Buy
+1,450
New +$245K 0.07% 102

Other funds holding BIIB

Prasad Wealth Partners's BIIB Position: Q3 2026 in Review

Prasad Wealth Partners increased its Biogen (BIIB) stake by 7.1% in Q3 2026, buying an estimated $21.8K and bringing the position to 1,553 shares worth $351K. The position accounts for 0.08% of the portfolio, ranked #117.

Prasad Wealth Partners first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. 620 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Prasad Wealth Partners held 1,553 shares of Biogen worth $351K as of Q3 2026.
  • Prasad Wealth Partners bought 103 Biogen shares in Q3 2026, an estimated $21.8K.
  • Biogen made up 0.08% of Prasad Wealth Partners's portfolio in Q3 2026, its #117 holding.
  • Prasad Wealth Partners first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • 620 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Prasad Wealth Partners's 13F filing for Q3 2026, filed 10 Nov 2026.